<< Back

November 18-20, 2026, 38th EORTC-NCI-AACR Symposium 2026

Novel HBS1L degraders identified from A-PROX and Directed Neosubstrate Degrader (DNsD) platforms for the treatment of FOCAD-deleted cancers